PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY

Authors
LATREILLE J GELMON K EISENHAUER E TOLCHER A FISHER B VERNILLET L DAIGNEAULT L HOSTETLERYANOWITZ C LEBECQ A BESENVAL M
Citation
J. Latreille et al., PHASE-I TRIAL OF THE NEW TAXOID RPR 109881A IN A DAY 1 AND 8 INTRAVENOUS (IV) SCHEDULE EVERY 3 WEEKS - AN NCI CANADA CLINICAL-TRIALS GROUP-STUDY, Annals of oncology, 9, 1998, pp. 382-382
Citations number
NO
Categorie Soggetti
Oncology
Journal title
Annals of oncology → ACNP
ISSN journal
09237534
Volume
9
Year of publication
1998
Supplement
2
Pages
382 - 382
Database
ISI
SICI code
0923-7534(1998)9:<382:PTOTNT>2.0.ZU;2-H